The FCRL3 −169T>C polymorphism has also been identified as a risk factor of various autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Hashimoto thyroiditis, Graves’ disease, and biliary cirrhosis [10, 28]. Here, FCRL3 is linked to Graves disease.